FIELD: medicine.
SUBSTANCE: method involves implanting porous titanium nickelide structures under skin. Umbilical trunk cells are cultivated thereon in the amount of 50 mcl per each implanted porous structure with cell content equal to 2 million of umbilical trunk cells per one porous titanium nickelide structure. One porous titanium nickelide structure is implanted per 7-10 kg of body mass. Implantation is carried out in particular case once in 5-6 months to clinical recovery.
EFFECT: stopped gangrene progress; retained maximum length and functional state of supporting lower extremity; prolonged patient survival period.
2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING ONCOLOGIC PATIENTS | 2004 |
|
RU2285548C2 |
| IMPLANT FOR SURGICAL TREATMENT OF INTERNAL ORGAN DISEASES | 1997 |
|
RU2143867C1 |
| DEVICE FOR CARRYING CELLULAR CULTURES OF ARTIFICIAL VISCERAL ORGANS | 2000 |
|
RU2191607C2 |
| MIXTURE FOR PRODUCTION OF CELLULAR STRUCTURE CARRIER | 1999 |
|
RU2170645C2 |
| IMPLANT-CARRIER FOR SURGICAL TREATMENT OF DISEASES OF INTERNAL ORGANS | 2005 |
|
RU2300345C2 |
| METHOD FOR TRANSDERMAL ADMINISTRATION OF INSULIN AND DEVICE FOR IMPLEMENTING IT | 2012 |
|
RU2534521C2 |
| CANCER IMMUNOREHABILITAITON MODE | 2008 |
|
RU2377994C1 |
| METHOD OF TREATING PYO-NECROTIC PROCESSES OF TOES IN DIABETIC FOOT SYNDROME | 2019 |
|
RU2704471C1 |
| METHOD OF TREATMENT OF ISCHEMIC ANGIOPATHY OF LOWER EXTREMITY VESSELS | 2017 |
|
RU2649498C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH DIABETES MIELLITIS AND NECROSIS OF THE SECOND, THIRD AND/OR THE FORTH TOE | 2010 |
|
RU2441615C1 |
